Interestingly, in the MRL/lpr lupus mouse-model, characterized by TFH hyperactivity and Tregs dysfunction, BTLA deficiency leads to exacerbation of lupus symptoms and reduced survival, suggesting that the BTLA pathway plays important roles in controlling the disease development (21). The gene discussed is BTLA; the disease is systemic lupus erythematosus.